300 related articles for article (PubMed ID: 26568423)
1. ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population.
Wang J; Xu C; Xun Y; Lu Z; Shi J; Yu C; Li Y
Sci Rep; 2015 Nov; 5():16494. PubMed ID: 26568423
[TBL] [Abstract][Full Text] [Related]
2. The ZJU index is a powerful index for identifying NAFLD in the general Chinese population.
Li L; You W; Ren W
Acta Diabetol; 2017 Oct; 54(10):905-911. PubMed ID: 28698957
[TBL] [Abstract][Full Text] [Related]
3. The ZJU index: a useful indicator for recognizing insulin resistance in the Chinese general population.
Ji B; Qu H; Wang H; Wei H; Deng H
Acta Diabetol; 2016 Oct; 53(5):817-23. PubMed ID: 27393006
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
[TBL] [Abstract][Full Text] [Related]
5. NAFL screening score: A basic score identifying ultrasound-diagnosed non-alcoholic fatty liver.
Zhou YJ; Zhou YF; Zheng JN; Liu WY; Van Poucke S; Zou TT; Zhang DC; Shen S; Shi KQ; Wang XD; Zheng MH
Clin Chim Acta; 2017 Dec; 475():44-50. PubMed ID: 28964832
[TBL] [Abstract][Full Text] [Related]
6. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
[TBL] [Abstract][Full Text] [Related]
7. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
[TBL] [Abstract][Full Text] [Related]
8. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
[TBL] [Abstract][Full Text] [Related]
9. Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms.
Lykiardopoulos B; Hagström H; Fredrikson M; Ignatova S; Stål P; Hultcrantz R; Ekstedt M; Kechagias S
PLoS One; 2016; 11(12):e0167776. PubMed ID: 27936091
[TBL] [Abstract][Full Text] [Related]
10. Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease.
Siddiqui MS; Patidar KR; Boyett S; Luketic VA; Puri P; Sanyal AJ
Liver Int; 2016 Apr; 36(4):572-9. PubMed ID: 26713759
[TBL] [Abstract][Full Text] [Related]
11. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].
Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475
[TBL] [Abstract][Full Text] [Related]
12. A simpler diagnostic formula for screening nonalcoholic fatty liver disease.
Feng G; He N; Zhou YF; Li XP; Niu C; Liu ML; Zhang KL; Li Y; Li YM; Zheng MH; Mi M
Clin Biochem; 2019 Feb; 64():18-23. PubMed ID: 30503530
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
14. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).
Purnomo HD; Mundhofir FE; Kasno ; Sudijanto E; Darmono ; Daldiyono ; Djokomoeljanto R; Faradz SM
Acta Med Indones; 2015 Jan; 47(1):16-23. PubMed ID: 25948763
[TBL] [Abstract][Full Text] [Related]
15. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study.
Zhang Y; He H; Zeng YP; Yang LD; Jia D; An ZM; Jia WG
Lipids Health Dis; 2020 Jun; 19(1):134. PubMed ID: 32527258
[TBL] [Abstract][Full Text] [Related]
17. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
[TBL] [Abstract][Full Text] [Related]
18. Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study.
Zheng K; Yin Y; Guo H; Ma L; Liu R; Zhao T; Wei Y; Zhao Z; Cheng W
Front Endocrinol (Lausanne); 2024; 15():1340644. PubMed ID: 38405152
[TBL] [Abstract][Full Text] [Related]
19. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
[TBL] [Abstract][Full Text] [Related]
20. Aminotransferase Ratio Is a Useful Index for Hepatosteatosis in Children and Adolescents: A Cross-Sectional Observational Study.
Lu CW; Lin MS; Lin YS; Chang IJ; Tsai MH; Wei KL; Chen MY
Gastroenterol Nurs; 2019; 42(6):486-495. PubMed ID: 31770351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
